Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiley A Chambers

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ophthalmology|June 5, 2012
Ophthalmic generics--are they really the same?Wiley A Chambers
Ophthalmology|October 7, 2004
Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug AdministrationMatt Feinsod, Wiley A Chambers
Ophthalmology|December 29, 2015
Good Ideas Gone Bad: The MIRAgel SagaJohn T Thompson, Wiley A Chambers
JAMA Ophthalmology|December 17, 2020
Using Historical Data to Support Approval of Drug Products for Ophthalmia Neonatorum: Innovative Approach Toward Evidence-Based MedicineHaihao Sun, Jean W Temeck, Susan K McCune, et al.
American Journal of Ophthalmology|December 25, 2015
Food and Drug Administration Procedures for New Drug and Device ApprovalsGary N Holland, Malvina B Eydelman, Brad Cunningham, et al.
Ophthalmology|November 5, 2003
Safe and effectiveAndrew P Schachat, Wiley A Chambers, Thomas J Liesegang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated TumorsJaleh Fallah, Michael H Brave, Chana Weinstock, et al.
JAMA Ophthalmology|December 4, 2025
Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event ReportingNeel D Pasricha, Stella K Kim, Asim V Farooq, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ophthalmology|June 5, 2012
Ophthalmic generics--are they really the same?Wiley A Chambers
Ophthalmology|October 7, 2004
Trials and tribulations: a primer on successfully navigating the waters of the Food and Drug AdministrationMatt Feinsod, Wiley A Chambers
Ophthalmology|December 29, 2015
Good Ideas Gone Bad: The MIRAgel SagaJohn T Thompson, Wiley A Chambers
JAMA Ophthalmology|December 17, 2020
Using Historical Data to Support Approval of Drug Products for Ophthalmia Neonatorum: Innovative Approach Toward Evidence-Based MedicineHaihao Sun, Jean W Temeck, Susan K McCune, et al.
American Journal of Ophthalmology|December 25, 2015
Food and Drug Administration Procedures for New Drug and Device ApprovalsGary N Holland, Malvina B Eydelman, Brad Cunningham, et al.
Ophthalmology|November 5, 2003
Safe and effectiveAndrew P Schachat, Wiley A Chambers, Thomas J Liesegang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated TumorsJaleh Fallah, Michael H Brave, Chana Weinstock, et al.
JAMA Ophthalmology|December 4, 2025
Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event ReportingNeel D Pasricha, Stella K Kim, Asim V Farooq, et al.
Pageof 1